Prestige Biologics Co., Ltd. (KOSDAQ:334970)
1,798.00
-6.00 (-0.33%)
At close: Jul 28, 2026
-53.78% (1Y)
| Market Cap | 139.80B -53.8% |
| Revenue (ttm) | 18.03B +168.6% |
| Net Income | -35.42B |
| EPS | -410.69 |
| Shares Out | 77.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 163,260 |
| Open | 1,810.00 |
| Previous Close | 1,804.00 |
| Day's Range | 1,715.00 - 1,810.00 |
| 52-Week Range | 1,650.00 - 3,950.00 |
| Beta | 0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |